| Breakdown | TTM | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 39.81B | 39.08B | 34.47B | 31.12B | 29.00B | 28.48B |
| Gross Profit | 7.27B | 6.58B | 4.54B | 826.00M | 3.36B | 3.42B |
| EBITDA | 4.79B | 4.29B | 1.42B | -1.71B | 1.05B | 1.07B |
| Net Income | 1.89B | 1.41B | 1.19B | -4.53B | -467.00M | -453.00M |
Balance Sheet | ||||||
| Total Assets | 60.19B | 56.64B | 50.87B | 47.91B | 51.17B | 44.14B |
| Cash, Cash Equivalents and Short-Term Investments | 11.80B | 10.19B | 7.25B | 4.59B | 8.52B | 5.92B |
| Total Debt | 3.83B | 3.96B | 3.77B | 4.78B | 3.22B | 2.73B |
| Total Liabilities | 48.59B | 45.96B | 41.51B | 39.12B | 33.99B | 28.92B |
| Stockholders Equity | 11.28B | 10.30B | 9.07B | 8.50B | 17.19B | 14.96B |
Cash Flow | ||||||
| Free Cash Flow | 5.47B | 4.10B | 1.38B | 394.00M | 1.06B | 959.00M |
| Operating Cash Flow | 7.28B | 5.82B | 2.89B | 1.62B | 2.22B | 1.95B |
| Investing Cash Flow | -1.92B | -1.62B | 1.25B | -1.63B | -1.12B | -958.00M |
| Financing Cash Flow | -1.36B | -1.14B | -2.26B | -1.13B | -568.00M | -340.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | €2.03B | 6.65 | 10.90% | 2.84% | 4.20% | -20.71% | |
76 Outperform | €10.73B | 25.10 | 25.25% | ― | 1.27% | 384.94% | |
76 Outperform | €2.03B | 6.74 | 0.33% | 2.76% | 4.20% | -20.71% | |
72 Outperform | €134.94B | 38.10 | 18.13% | ― | 13.38% | 22.22% | |
70 Outperform | €161.45B | 22.98 | 12.93% | 2.18% | 2.11% | 16.48% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
54 Neutral | €1.31B | 7.70 | 17.73% | 3.12% | -18.21% | -137.62% |